Proportion of minor heterozygous plus homozygous (among subjects with all genotypes) | CKD (+) | CKD (-) | OR* | 95% CI* | P interaction # | |||
---|---|---|---|---|---|---|---|---|
(n = 564) | (n = 2,704) | Â | Â | Â | ||||
Genotype | BMI | N | (%) | N | (%) | Â | Â | Â |
APOA5 T-1131C | Â | Â | Â | Â | Â | Â | Â | |
(rs662799) | Â | Â | Â | Â | Â | Â | Â | Â |
 | ≥ 30 | 15/16 | (93.8) | 54/95 | (56.8) | 12.39 | 1.55-99.09 |  |
 | < 30 | 328/548 | (59.9) | 1,453/2,609 | (55.7) | 1.21 | 0.999-1.47 | 0.028 |
APOA5 T1259C | Â | Â | Â | Â | Â | Â | Â | |
(rs2266788) | Â | Â | Â | Â | Â | Â | Â | Â |
 | ≥ 30 | 13/16 | (81.3) | 50/95 | (52.6) | 3.68 | 0.97-13.93 |  |
 | < 30 | 269/548 | (49.1) | 1,217/2,609 | (46.6) | 1.14 | 0.95-1.38 | 0.079 |